期刊文献+

TLC法检测熊去氧胆酸中的胆石酸 被引量:2

Determination of lithocholic acid in Ursodeoxycholic acid by TLC
原文传递
导出
摘要 目的采用TLC法测定熊去氧胆酸中胆石酸的含量。方法采用硅胶G薄层板,以二氯甲烷-丙酮-冰醋酸(85∶5∶3)为展开剂,10%磷钼酸的硫酸-冰醋酸(1∶20)溶液为显色剂。结果 TLC法能有效检出熊去氧胆酸中的胆石酸,检测限为0.02μg。结论所用方法专属性好、灵敏度高,可用于熊去氧胆酸中胆石酸的检查。 OBJECTIVE To establish a method for the examination of lithocholic acid in ursodeoxycholic acid by TLC.METHODS Silica gel G was used as stationary phase and a mixture of dichloromethane,acetone and glacial acetic acid(85:5:3) was used as mobile phase.The color-developing reagent was 10% phosphomolybdic acid in concentrated sulfuric acid and glacial acetic acid solution(1:20).RESULTS The method was proved effective to detect lithocholic acid and the detection limit was 0.02 μg.CONCLUSION This method is specific,sensitive and can be used to examine lithocholic acid in ursodeoxychlic acid.
出处 《华西药学杂志》 CAS CSCD 北大核心 2012年第5期593-594,共2页 West China Journal of Pharmaceutical Sciences
关键词 熊去氧胆酸 胆石酸 薄层色谱法 Ursodeoxycholic acid Lithocholic acid Thin layer chromatography
  • 相关文献

参考文献4

二级参考文献37

  • 1Paumgartner G, Beuers U. Ursodeoxycholic acid in eholestatic liver disease:mechanism of action and therapeutic use revisited. Hepatolory, 2002,36 : 525-531.
  • 2Beuers U, Bilzer M, Chittattu A, et al. Tauroursodeoxycholic acid inserts the apical coniugate export pump,Mrp2,into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in choles tatic rat liver. Hepatology ,2001,33 : 1206- 1216.
  • 3Marschall HU. Complementary stimulation of hepatobiliary trasport and detoxification systems by rifampicin and ursode oxycholic acid in humans. Gastroenterology , 2005, 129: 476-485.
  • 4Lazaridis KN. Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders. J Hepatol, 2001, 35: 134-146.
  • 5Qiao L, Yacoub A,Studer E, et al. Inhibition of the MAPK and PI3K pathways enhances UDCA induced apoptosis in primary rodent hepatocytes. Hepatology,2002,35:779- 789.
  • 6Beuers U. Drug insight:mechanisms and sites of action of ursodexycholic acid in cholestasis. Gastroenterology & Hepatology, 2006,3:318- 328.
  • 7Corpechot C, Carrat F, Bonnand AM, et al. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. H epatology, 2000,32 : 1196- 1199.
  • 8Poupon RE. Ten year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA PBC study Group. Hepatology,1999, 29; 1668- 1671.
  • 9Pieter C J, Solko W, Bettina E,et al. Progosis of ursodeoxycholic acid treated patients with primary biliary cirrhosis. Results of a 10-Yr cohort study involving 297 Patients. Am J Gastroenterol, 2006,101 = 2044-20511.
  • 10Angulo P, Diekson ER, Therneau TM, et al. Comparison of three doses of ursodeoxycholie acid in the treatment of primary biliary cirrhosis:a randomized trial. J Hepatol, 1999, 30: 830-835.

共引文献34

同被引文献6

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部